Form 4 holding
10%+ Owner
Lexeo Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 1,835,959
- Estimated value
- $24,268,808
- Report date
- 07 Nov 2023
- Price
- $13.22
- Ownership
- Direct
Invest A/s Lundbeckfond - 10%+ Owner at Lexeo Therapeutics, Inc.
Issuer-level insider activity
- Role
- 10%+ Owner
- Issuer ticker
- LXEO on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Invest A/s Lundbeckfond since 13 Sep 2025
Reported holdings for Invest A/s Lundbeckfond in Lexeo Therapeutics, Inc.
Form 4 holding
10%+ Owner
Lexeo Therapeutics, Inc.
- Security class
- Series A convertible preferred stock
- Shares / value
- 0
- Estimated value
- Report date
- 07 Nov 2023
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
10%+ Owner
Lexeo Therapeutics, Inc.
- Security class
- Series B convertible preferred stock
- Shares / value
- 0
- Estimated value
- Report date
- 07 Nov 2023
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Invest A/s Lundbeckfond in Lexeo Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.